Breakthrough in Stroke Care: The 2026 Launch of CEREGLIDE™ Catheters
A Big Step Forward in Brain Surgery in an Emergency
Today, February 26, 2026, is a very important day in the fight against stroke. The CEREGLIDETM line of aspiration tubes from Johnson & Johnson MedTech is now complete. The CEREGLIDE® 42 and CEREGLIDE® 57 are now on the market, along with the INNERGLIDE® 7 delivery aid.
This is more than just a new tool to me as a health worker; it’s a way to solve one of the hardest problems in neurosurgery: how to get to the “unreachable.” Millions of brain cells are killed every second after a stroke. Distal occlusions are blood clots that are deep in the brain’s smaller, curved veins. In the past, they were very hard to get to. That story is supposed to change with these new tools.
Going Down: How Well Distal Navigation Works
During a mechanical thrombectomy (surgery to remove a blood clot), the main goal is to get the blood moving again as quickly as possible. Different levels of hardness are used to make the CEREGLIDETM family.
To make it through the brain's tiny, "twisted" vessels without hurting them, the end of the catheter is soft and bendable.
Supportive Proximal Control: The base of the catheter stays strong, which helps doctors reach larger arteries.
With this balance, doctors can aim more accurately at the M2 part of the brain, which is made up of the secondary branches of the middle cerebral artery. Getting to these places used to feel like trying to thread a needle while driving a car that was moving. It is now easier to track with TruCourseTM Technology, which means that fewer “passes” are needed to get past a blockage.
This is the “aspiration-first” benefit
Going forward in 2026, the medical field will use the “aspiration-first” method. In this method, the clot is pulled straight into the tube by strong suction instead of just being grabbed by a wire mesh (stent retriever).
This whole process is easier thanks to CEREGLIDETM technology. A multi-axial system is used to make sure that all of the devices work properly with each other. This “plug-and-play” compatibility means that surgeons can save more brain tissue and spend less time picking out tools when time is of the essence.
Why your family needs to do this
When a family member has an ischaemic stroke and is taken to the hospital, having this tools could mean the difference between them fully recovering or being unable to do things for the rest of their lives.
As a result, we can treat more patients easily because doctors can reach blood vessels farther away. Now we can clean up the “side streets” where smaller but still dangerous blood clots tend to hide. The “main highways” of the brain are no longer the only ones we can use.
The Brite-LineTM Technology in these catheters also lets the surgeon see where the device is at all times during the process.
What Will Happen Next with Ischaemic Care?
Getting this catheter family finished shows that you care about consistency. Now, hospitals only need one “toolbox” to deal with both large vascular occlusions and difficult distal blocks. Because of this, procedures go more quickly, there are fewer problems, and more people are able to go home to their families.
Health Disclaimer
This article provides general information about new medical technologies and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified neurosurgeon or emergency medical team regarding a stroke or any other medical condition. In the event of a stroke, call emergency services (such as 911) immediately. DrugsArea
Sources & References
- Johnson & Johnson MedTech Official Press Release,
- Journal of NeuroInterventional Surgery,
- American Heart Association – Stroke Tech 2026,
- FDA Medical Device Registry
